VALUE DRUG, LIMITED — United States · Federal contract register · Supplier record: 1 contracts, all years ($235,650 · Nov 2025 – Nov 2025); $236K since January 2024 (1 contract · 1 agency); 82nd rank in the line (of 147 suppliers · 0.07%); 5 agencies never served ($271M on the line without VALUE DRUG, LIMITED).
Assay record ASY-US-1TVSHIZ06A · Cite as: Assay Systems, “VALUE DRUG, LIMITED in the USAspending register”, https://assay-systems.com/register/us/value-drug-limited/
1
contracts, all years
$235,650 · Nov 2025 – Nov 2025
$236K
since January 2024
1 contract · 1 agency
82nd
rank in the line
of 147 suppliers · 0.07%
5
agencies never served
$271M on the line without VALUE DRUG, LIMITED
Own record by year
2025 onward
$236K
20252026
Who buys from VALUE DRUG, LIMITED
since January 2024
1agencies
$236Kpaid
100.0%top buyer
Department of Defense100.0%
$235,650
The line
since January 2024
$358Mline value
652contracts
6agencies
147suppliers
65.2%held by top ten
Pharmacy services (Q517)
$133M
$112M
$113M
202420252026Jan–Sep
82ndof 147 suppliers
$235,650VALUE DRUG, LIMITED in the line
0.07%share of the line
0.3%of $86,763,647 spent by Department of Defense
Agencies that buy the line and never bought from VALUE DRUG, LIMITED
5agencies
613contracts
$271,368,486since January 2024
Department of Veterans Affairs302 contracts
$220,313,016
Department of Health and Human Services78 contracts
Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.